VASH1 and neoplasm: Assessing angiogenesis-regulating markers, including VASH1, VASH2, and iNOS, in circulating WBCs provides deeper insights into the tumor microenvironment and immune response in HNSCC, surpassing the limitations of plasma measurements alone.